Accelerated Ab Discovery Targeting The Sars-Cov-2 Spike Protein For Covid-19 Therapeutic Potential

Accelerated Ab Discovery Targeting the SARS-CoV-2 Spike Protein for COVID-19 Therapeutic Potential

Twist Bioscience

Accelerated High-Throughput and High-Content Antibody Discovery Targeting SARS-CoV-2 Spike Protein

[Webinar] Targeting SARS-CoV-2: A Suite of Assays to Accelerate Drug Discovery by Reaction Biology

Targeting Spike protein for effective vaccine and therapeutics against SARS-CoV-2

Efforts by the OTS community to combat SARS-CoV-2 and COVID-19

Oligonucleotide Therapeutics Society

SARS-CoV-2 coronavirus spike protein under siege

UBC Media Relations

The-Scientist Symposium: Accelerating Discovery in the Age of a Pandemic

Characterization and selection of antibodies for COVID-19 diagnostics

Sino Biological, Inc.

Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2 and Other Viral Pandemics

Aptamer-Based Detection and Blocking of the SARS CoV-2 Spike Glycoprotein | Andrej Luptak, PhD | UCI

UCI School of Medicine

Discovery of a druggable pocket in SARS-CoV-2 Spike: New avenue to defeat COVID-19?

COVID19 Drug Discovery : SARS CoV 2 Protein Targets

Girinath Pillai

Rapid Discovery of Therapeutic Antibodies to Combat COVID-19 at Twist Bioscience

3-11-21 - Impact of SARS-CoV-2 spike protein variation on therapeutics and vaccines

WashU Med Department of Medicine

Accelerating Drug Discovery to Fight COVID with AI

COVID 19 vaccination activates antibodies targeting parts of virus spike protein

Medical Dialogues

Science of COVID-19: “Protein interaction map of SARS-CoV-2, with implications for drug targets."

Howard Hughes Medical Institute (HHMI)

Accelerating the process from basic drug discovery to clinical trial for Covid-19 - SciLifeLab

How spike protein discoveries drove coronavirus vaccine design

Scripps Research

Enhancing strategies for COVID-19 solutions in diagnosis, vaccine development and therapies

GenScript USA Inc.